1536 related articles for article (PubMed ID: 36115602)
1. 23-O-acetylshengmanol-3-O-α-L-arabinoside alleviates lipopolysaccharide-induced acute lung injury through inhibiting IκB/NF-κB and MAPK/AP-1 signaling pathways.
Chen C; Li L; Liu X; Zhang D; Liu Y; Li Y
J Ethnopharmacol; 2023 Jan; 300():115725. PubMed ID: 36115602
[TBL] [Abstract][Full Text] [Related]
2. Physalin B ameliorates inflammatory responses in lipopolysaccharide-induced acute lung injury mice by inhibiting NF-κB and NLRP3 via the activation of the PI3K/Akt pathway.
Zhong R; Xia T; Wang Y; Ding Z; Li W; Chen Y; Peng M; Li C; Zhang H; Shu Z
J Ethnopharmacol; 2022 Feb; 284():114777. PubMed ID: 34737012
[TBL] [Abstract][Full Text] [Related]
3. Hederasaponin C Alleviates Lipopolysaccharide-Induced Acute Lung Injury
Han S; Yuan R; Cui Y; He J; Wang QQ; Zhuo Y; Yang S; Gao H
Front Immunol; 2022; 13():846384. PubMed ID: 35281058
[TBL] [Abstract][Full Text] [Related]
4. Eupalinolide B attenuates lipopolysaccharide-induced acute lung injury through inhibition of NF-κB and MAPKs signaling by targeting TAK1 protein.
Yang L; Chen H; Hu Q; Liu L; Yuan Y; Zhang C; Tang J; Shen X
Int Immunopharmacol; 2022 Oct; 111():109148. PubMed ID: 35988521
[TBL] [Abstract][Full Text] [Related]
5. Sichen Formula Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via Blocking the TLR4 Signaling Pathways.
Yan LS; Cui S; Cheng BC; Yin XB; Wang YW; Qiu XY; Nima CR; Zhang Y; Zhang SF
Drug Des Devel Ther; 2023; 17():297-312. PubMed ID: 36756190
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory effect of the six compounds isolated from Nauclea officinalis Pierrc ex Pitard, and molecular mechanism of strictosamide via suppressing the NF-κB and MAPK signaling pathway in LPS-induced RAW 264.7 macrophages.
Li D; Chen J; Ye J; Zhai X; Song J; Jiang C; Wang J; Zhang H; Jia X; Zhu F
J Ethnopharmacol; 2017 Jan; 196():66-74. PubMed ID: 27989509
[TBL] [Abstract][Full Text] [Related]
7. O-Methylbulbocapnine and Dicentrine Suppress LPS-Induced Inflammatory Response by Blocking NF-κB and AP-1 Activation through Inhibiting MAPKs and Akt Signaling in RAW264.7 Macrophages.
Yodkeeree S; Ooppachai C; Pompimon W; Limtrakul Dejkriengkraikul P
Biol Pharm Bull; 2018; 41(8):1219-1227. PubMed ID: 30068871
[TBL] [Abstract][Full Text] [Related]
8. Eugenolol and glyceryl-isoeugenol suppress LPS-induced iNOS expression by down-regulating NF-kappaB AND AP-1 through inhibition of MAPKS and AKT/IkappaBalpha signaling pathways in macrophages.
Yeh JL; Hsu JH; Hong YS; Wu JR; Liang JC; Wu BN; Chen IJ; Liou SF
Int J Immunopathol Pharmacol; 2011; 24(2):345-56. PubMed ID: 21658309
[TBL] [Abstract][Full Text] [Related]
9. Plantanone C attenuates LPS-stimulated inflammation by inhibiting NF-κB/iNOS/COX-2/MAPKs/Akt pathways in RAW 264.7 macrophages.
Fang Y; Yang L; He J
Biomed Pharmacother; 2021 Nov; 143():112104. PubMed ID: 34474343
[TBL] [Abstract][Full Text] [Related]
10. DXXK exerts anti-inflammatory effects by inhibiting the lipopolysaccharide-induced NF-κB/COX-2 signalling pathway and the expression of inflammatory mediators.
Yu Y; Li X; Qu L; Chen Y; Dai Y; Wang M; Zou W
J Ethnopharmacol; 2016 Feb; 178():199-208. PubMed ID: 26571085
[TBL] [Abstract][Full Text] [Related]
11. Overexpressing six-transmembrane protein of prostate 2 (STAMP2) alleviates sepsis-induced acute lung injury probably by hindering M1 macrophage polarization via the NF-κB pathway.
Ji L; Shi X; Wang G; Wu H; Hu Z
Folia Histochem Cytobiol; 2023; 61(1):34-46. PubMed ID: 36583372
[TBL] [Abstract][Full Text] [Related]
12. Sclareol ameliorate lipopolysaccharide-induced acute lung injury through inhibition of MAPK and induction of HO-1 signaling.
Hsieh YH; Deng JS; Pan HP; Liao JC; Huang SS; Huang GJ
Int Immunopharmacol; 2017 Mar; 44():16-25. PubMed ID: 28068646
[TBL] [Abstract][Full Text] [Related]
13. Dingchuan tang essential oil inhibits the production of inflammatory mediators via suppressing the IRAK/NF-κB, IRAK/AP-1, and TBK1/IRF3 pathways in lipopolysaccharide-stimulated RAW264.7 cells.
Zhang Y; Guo H; Cheng BC; Su T; Fu XQ; Li T; Zhu PL; Tse KW; Pan SY; Yu ZL
Drug Des Devel Ther; 2018; 12():2731-2748. PubMed ID: 30233137
[TBL] [Abstract][Full Text] [Related]
14. Shiwei Qingwen decoction regulates TLR4/NF-κB signaling pathway and NLRP3 inflammasome to reduce inflammatory response in lipopolysaccharide-induced acute lung injury.
Zhang Q; Yang C; Ma S; Guo S; Hu X; Zhou Z; Liu Y; Zhang X; Jiang R; Zhang Z; Wen L
J Ethnopharmacol; 2023 Sep; 313():116615. PubMed ID: 37164255
[TBL] [Abstract][Full Text] [Related]
15. Acacia catechu (L.f.) Willd and Scutellaria baicalensis Georgi extracts suppress LPS-induced pro-inflammatory responses through NF-кB, MAPK, and PI3K-Akt signaling pathways in alveolar epithelial type II cells.
Feng T; Zhou L; Gai S; Zhai Y; Gou N; Wang X; Zhang X; Cui M; Wang L; Wang S
Phytother Res; 2019 Dec; 33(12):3251-3260. PubMed ID: 31506998
[TBL] [Abstract][Full Text] [Related]
16. The p38 MAPK inhibitor JLU1124 inhibits the inflammatory response induced by lipopolysaccharide through the MAPK-NF-κB pathway in RAW264.7 macrophages.
Li XN; Su J; Zhao L; Xiang JB; Wang W; Liu F; Li HY; Zhong JT; Bai X; Sun LK
Int Immunopharmacol; 2013 Nov; 17(3):785-92. PubMed ID: 24070708
[TBL] [Abstract][Full Text] [Related]
17. Shufeng Jiedu capsule inhibits inflammation and apoptosis by activating A2AAR and inhibiting NF-κB to alleviate LPS-induced ALI.
Cai J; Wang YL; Sheng XD; Zhang L; Lv X
J Ethnopharmacol; 2022 Nov; 298():115661. PubMed ID: 36002086
[TBL] [Abstract][Full Text] [Related]
18. Cnidilide, an alkylphthalide isolated from the roots of Cnidium officinale, suppresses LPS-induced NO, PGE
Lee WS; Shin JS; Jang DS; Lee KT
Int Immunopharmacol; 2016 Nov; 40():146-155. PubMed ID: 27591413
[TBL] [Abstract][Full Text] [Related]
19. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
[TBL] [Abstract][Full Text] [Related]
20. (E)-3-(3,4-Dimethoxyphenyl)-1-(5-hydroxy-2,2-dimethyl-2H-chromen-6-yl)prop-2-en-1-one ameliorates the collagen-arthritis via blocking ERK/JNK and NF-κB signaling pathway.
Li X; Peng F; Xie C; Wu W; Han X; Chen L
Int Immunopharmacol; 2013 Dec; 17(4):1125-33. PubMed ID: 24135236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
